Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging
| Status: | Withdrawn |
|---|---|
| Conditions: | Prostate Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - 80 |
| Updated: | 7/22/2018 |
| Start Date: | June 2007 |
The goal is to develop MR imaging techniques to improve delineation of cancer extent, and to
improve differential diagnosis between prostate cancer and benign prostate hyperplasia or
other benign diseases.
improve differential diagnosis between prostate cancer and benign prostate hyperplasia or
other benign diseases.
Inclusion Criteria:
1. A male older than 21 years of age and under age of 80,
2. Either a normal healthy volunteer; a patient who has confirmed prostate cancer and
decided to receive prostatectomy; or a patient who has persistent elevated PSA higher
than 4.0 ng/ml, and with a prior benign biopsy scheduled to receive the second biopsy.
Exclusion Criteria:
1. Unwilling to give informed consent,
2. Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices, surgical
clips (hemostatic clips) or other metallic implants,
3. Have engaged in occupations or activities which may cause accidental lodging of
ferromagnetic materials, or have imbedded metal fragments from military activities,
4. Have received orthodontic work involving ferromagnetic materials,
5. Claustrophobic,
6. Unable to lie down still for 60 minutes.
We found this trial at
1
site
Click here to add this to my saved trials
